The Functional Assessment of Cancer Therapy – General (FACT-G) is valid for monitoring quality of life in non-Hodgkin lymphoma patients

von Yost, KJ, Thompson, CA, Eton, DT, Allmer, C, Ehlers, SL, Habermann, TM, Shanafelt, TD, Maurer, MJ, Slager, SL, Link, BK, Cerhan, JR
Veröffentlicht 2012

Event-Free Survival at 24 Months Captures Central Nervous System Relapse of Systemic Diffuse Large B-cell Lymphoma in the Immunochemotherapy Era

von Thanarajasingam, G, Maurer, MJ, Farooq, U, Johnston, PB, Thompson, CA, Bennani, NN, Ansell, SM, Porrata, LF, Macon, WR, Syrbu, SI, Cerhan, JR, Habermann, TM, Link, BK, Witzig, TE, Nowakowski, GS
Veröffentlicht in Br J Haematol (2017)

Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma

von Hu, G, Dasari, S, Asmann, YW, Greipp, PT, Knudson, RA, Benson, HK, Li, Y, Eckloff, BW, Jen, Jin, Link, BK, Jiang, L, Sidhu, JS, Wellik, LE, Witzig, TE, Bennani, NN, Cerhan, JR, Boddicker, RL, Feldman, AL
Veröffentlicht in Leukemia (2017)

A Meta-Analysis of Hodgkin Lymphoma Reveals 19p13.3 TCF3 as a Novel Susceptibility Locus

von Cozen, W, Timofeeva, MN, Li, D, Diepstra, A, Hazelett, D, Delahaye-Sourdeix, M, Edlund, CK, Franke, L, Rostgaard, K, Van Den Berg, DJ, Cortessis, VK, Smedby, KE, Glaser, SL, H-J, Westra, Robison, LL, Mack, TM, Ghesquieres, H, Hwang, AE, Nieters, A, de Sanjose, S, Lightfoot, T, Becker, N, Maynadie, M, Foretova, L, Roman, E, Benavente, Y, Rand, KA, Nathwani, BN, Glimelius, B, Staines, A, Boffetta, P, Link, BK, Kiemeney, L, Ansell, SM, Bhatia, S, Strong, LC, Galan, P, Vatten, L, Habermann, TM, Duell, EJ, Lake, A, Veenstra, RN, Visser, L, Liu, Y, Urayama, KY, Montgomery, D, Gaborieau, V, Weiss, LM, Byrnes, G, Lathrop, M, Cocco, P, Best, T, Skol, AD, H-O, Adami, Melbye, M, Cerhan, JR, Gallagher, A, Taylor, GM, Slager, SL, Brennan, P, Coetzee, GA, Conti, DV, Onel, K, Jarrett, RF, Hjalgrim, H, van den Berg, A, McKay, JD
Veröffentlicht 2014